Effectiveness of a mindfulness-based intervention for persons with early psychosis: A multi-site randomized controlled trial
- PMID: 38290375
- DOI: 10.1016/j.schres.2024.01.014
Effectiveness of a mindfulness-based intervention for persons with early psychosis: A multi-site randomized controlled trial
Abstract
Background: The Mindfulness Ambassador Program (MAP) is a group-based, facilitated mindfulness-based intervention (MBI). We sought to determine the effectiveness of MAP on reducing negative psychotic symptoms and enhancing mindfulness skills among persons experiencing early psychosis.
Methods: We conducted a pragmatic randomized controlled trial (RCT) at three early psychosis intervention (EPI) programs in Ontario, Canada. Participants (N = 59) were randomly assigned to receive MAP (n = 29) for 1-hour weekly sessions over 3 months, or to treatment as usual (TAU, n = 30). Assessments were conducted at baseline, 3 months, and 6 months using the Self-Evaluation of Negative Symptoms (SNS) and Kentucky Inventory of Mindfulness Skills (KIMS). Linear mixed methods were used to assess the joint effects of group and time.
Results: At 3 months, participants who received MAP (n = 17) demonstrated greater reductions on the SNS relative to TAU (n = 15), which were clinically and statistically significant (-4.1; 95%CI -7.5, -0.7; p = 0.019). At 6 months, the difference between MAP (n = 10) and TAU (n = 13) was no longer statistically significant (-1.2; 95%CI -5.2,2.7; p = 0.54). On the KIMS, no significant effects were found at 3 months (+0.3; 95%CI -2.0,2.5; p = 0.82) or 6 months (+0.4; 95%CI -2.2,2.9; p = 0.79).
Conclusions: We conducted one of the first multi-site RCTs of a MBI for early psychosis. Our findings indicated that MAP was more effective in reducing negative symptoms compared to TAU in the short term. Earlier reductions in negative psychotic symptoms may help facilitate recovery in the long term.
Keywords: Early intervention; Mindfulness; Negative symptoms; Psychotherapy; Psychotic disorders.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest AGM is CEO and Founder of the registered Canadian charity, The Global MINDS Collective. Mindfulness Without Borders gifted their trademarks and intellectual property, including the Mindfulness Ambassador Program, to the Global MINDS Collective in December 2022. The discussion and decision around the transfer of Mindfulness Without Borders to the Global MINDS Collective occurred following completion of the study and composition of the manuscript. All other authors have declared that there are no conflicts of interest in relation to the subject of this study.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
